Radiology Doctors in Elyria, OH Accepting Medicare

5 Radiology doctors found. Showing 1 - 5

Dr. David Barron, M.D./PH.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 41201 Schadden Rd, Elyria, OH 44035 Phone: 440-324-0451    Fax: 440-324-0441

Francis Joseph Moorhead, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 41201 Schadden Rd, Elyria, OH 44035 Phone: 440-324-0451    Fax: 440-324-0441

Dr. Joel H. Elconin, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 41201 Schadden Rd, Elyria, OH 44035 Phone: 440-324-0400    Fax: 440-324-0441

Dung B Nguyen, M.D. Radiology - Radiation Oncology Medicare: Medicare Enrolled Practice Location: 41201 Schadden Rd, Elyria, OH 44035 Phone: 440-324-0400    Fax: 440-324-0441

Dr. Martin L. Ribovich, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 41201 Schadden Rd, Elyria, OH 44035 Phone: 440-324-0440

News Archive

Positive results from VIVUS' Phase 3 study of avanafil for ED in men with diabetes

VIVUS, Inc. today announced positive results from the phase 3 REVIVE-Diabetes (TA-302) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) in men with type 1 and type 2 diabetes. The REVIVE-Diabetes study met all three primary endpoints across the two doses studied by demonstrating statistically significant improvement in erectile function as measured by the Sexual Encounter Profile (SEP) and improvements in the International Index of Erectile Function (IIEF) score.

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

Office-based medical practice can promote vaccination in adults

Promoting immunizations as a part of routine office-based medical practice is needed to improve adult vaccination rates, a highly effective way to curb the spread of diseases across communities, prevent needless illness and deaths, and lower health care costs, according to a new RAND Corporation study.

Researchers find Dpp protein causes metastatic tumour migration

One of the most intriguing questions in cancer research is what causes metastatic tumour migration, why some tumour cells manage to migrate to other parts of the body but others cells don't. International investigation conducted by Enrique Mart-n Blanco, CSIC researcher at the Institute of Biology of Barcelona, located in the Barcelona Science Park, reveals that cells make use of a natural mechanism for this.

Read more Medical News

› Verified 5 days ago